Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Steinberg

Showing results (581-590 of 692) with videos related to

Pageof 70
Sort By:
Brachytherapy|August 16, 2017
Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapyJohn V Hegde, D Jeffrey Demanes, Darlene Veruttipong, et al.
BJU International|February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Frontiers in Oncology|March 19, 2026
Association of ZIP code sociodemographic characteristics with radiation oncology services, payments, and technique utilizationPatrick Travis Courtney, Myung-Shin Sim, Michelle A Eala, et al.
Brachytherapy|July 6, 2021
Intravascular coronary brachytherapy combined with a drug-coated balloonKathleen E Kearney, Kent Wallner, Minsun Kim, et al.
Practical Radiation Oncology|October 4, 2015
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesotheliomaAmar U Kishan, Robert B Cameron, Pin-Chieh Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trialJohn Nikitas, Lauren M Smith, Yu Gao, et al.
Frontiers in Oncology|May 7, 2020
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate CancerRebecca Levin-Epstein, George Qiao-Guan, Jesus E Juarez, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|January 13, 2016
A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancerCatherine Merna, Jean-Claude M Rwigema, Minsong Cao, et al.
BMC Cancer|May 12, 2021
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trialTing Martin Ma, James M Lamb, Maria Casado, et al.
Journal of Endourology|July 15, 2020
Initial Results from the M-STONE Group: A Multi-Center Collaboration to Study Treatment Outcomes in Nephrolithiasis EvaluationBrett A Johnson, Sara L Best, Stephen Y Nakada, et al.
Pageof 70

Showing results (581-590 of 692) with videos related to

Sort By:
Pageof 70
Brachytherapy|August 16, 2017
Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapyJohn V Hegde, D Jeffrey Demanes, Darlene Veruttipong, et al.
BJU International|February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Frontiers in Oncology|March 19, 2026
Association of ZIP code sociodemographic characteristics with radiation oncology services, payments, and technique utilizationPatrick Travis Courtney, Myung-Shin Sim, Michelle A Eala, et al.
Brachytherapy|July 6, 2021
Intravascular coronary brachytherapy combined with a drug-coated balloonKathleen E Kearney, Kent Wallner, Minsun Kim, et al.
Practical Radiation Oncology|October 4, 2015
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesotheliomaAmar U Kishan, Robert B Cameron, Pin-Chieh Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trialJohn Nikitas, Lauren M Smith, Yu Gao, et al.
Frontiers in Oncology|May 7, 2020
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate CancerRebecca Levin-Epstein, George Qiao-Guan, Jesus E Juarez, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|January 13, 2016
A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancerCatherine Merna, Jean-Claude M Rwigema, Minsong Cao, et al.
BMC Cancer|May 12, 2021
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trialTing Martin Ma, James M Lamb, Maria Casado, et al.
Journal of Endourology|July 15, 2020
Initial Results from the M-STONE Group: A Multi-Center Collaboration to Study Treatment Outcomes in Nephrolithiasis EvaluationBrett A Johnson, Sara L Best, Stephen Y Nakada, et al.
Pageof 70